Our integrative analysis showed that among these 31 genes, CDKN2A and MTAP were the only two genes displaying significant correlation with tumor-immune phenotypes, patient responses to ICT, and patient survival (Supplementary Fig. 22). The gene discussed is CDKN2A; the disease is neoplasm.